A citation-based method for searching scientific literature

Benjamin D Leibowitz, Bonnie V Dougherty, Joshua S K Bell, Joshuah Kapilivsky, Jackson Michuda, Andrew J Sedgewick, Wesley A Munson, Tushar A Chandra, Jonathan R Dry, Nike Beaubier, Catherine Igartua, Timothy Taxter. BMC Cancer 2022
Times Cited: 4







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung,[...]. Clin Cancer Res 2016
492
75

Pan-cancer landscape of homologous recombination deficiency.
Luan Nguyen, John W M Martens, Arne Van Hoeck, Edwin Cuppen. Nat Commun 2020
133
75



Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
50

OncoKB: A Precision Oncology Knowledge Base.
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E Rudolph, Rona Yaeger, Tara Soumerai, Moriah H Nissan,[...]. JCO Precis Oncol 2017
50

Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
Talia Golan, Grainne M O'Kane, Robert E Denroche, Maria Raitses-Gurevich, Robert C Grant, Spring Holter, Yifan Wang, Amy Zhang, Gun Ho Jang, Chani Stossel,[...]. Gastroenterology 2021
45
50

Biomarkers for Homologous Recombination Deficiency in Cancer.
Michal M Hoppe, Raghav Sundar, David S P Tan, Anand D Jeyasekharan. J Natl Cancer Inst 2018
161
50

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
V Abkevich, K M Timms, B T Hennessy, J Potter, M S Carey, L A Meyer, K Smith-McCune, R Broaddus, K H Lu, J Chen,[...]. Br J Cancer 2012
412
50

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
Helen Davies, Dominik Glodzik, Sandro Morganella, Lucy R Yates, Johan Staaf, Xueqing Zou, Manasa Ramakrishna, Sancha Martin, Sandrine Boyault, Anieta M Sieuwerts,[...]. Nat Med 2017
493
50

Genome-wide transcriptome profiling of homologous recombination DNA repair.
Guang Peng, Curtis Chun-Jen Lin, Wei Mo, Hui Dai, Yun-Yong Park, Soo Mi Kim, Yang Peng, Qianxing Mo, Stefan Siwko, Ruozhen Hu,[...]. Nat Commun 2014
147
50

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.
R E Miller, A Leary, C L Scott, V Serra, C J Lord, D Bowtell, D K Chang, D W Garsed, J Jonkers, J A Ledermann,[...]. Ann Oncol 2020
116
50

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
50

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.
Tatiana Popova, Elodie Manié, Guillaume Rieunier, Virginie Caux-Moncoutier, Carole Tirapo, Thierry Dubois, Olivier Delattre, Brigitte Sigal-Zafrani, Marc Bollet, Michel Longy,[...]. Cancer Res 2012
375
50

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
50

Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.
Nicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, Aron C Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J Dirk Iglehart,[...]. Cancer Discov 2012
321
50

Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study.
Hongcheng Wang, Jiazhe Liu, Guanggai Xia, Shizhou Lei, Xiuyan Huang, Xinyu Huang. Sci Rep 2020
29
25

BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma.
Alex B Blair, Vincent P Groot, Georgios Gemenetzis, Jishu Wei, John L Cameron, Matthew J Weiss, Michael Goggins, Christopher L Wolfgang, Jun Yu, Jin He. J Am Coll Surg 2018
41
25

Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype.
Maeve A Lowery, Emmet J Jordan, Olca Basturk, Ryan N Ptashkin, Ahmet Zehir, Michael F Berger, Tanisha Leach, Brian Herbst, Gokce Askan, Hannah Maynard,[...]. Clin Cancer Res 2017
112
25


Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.
Jennifer P Morton, Paul Timpson, Saadia A Karim, Rachel A Ridgway, Dimitris Athineos, Brendan Doyle, Nigel B Jamieson, Karin A Oien, Andrew M Lowy, Valerie G Brunton,[...]. Proc Natl Acad Sci U S A 2010
430
25

Pancreatic Cancer: A Review.
Wungki Park, Akhil Chawla, Eileen M O'Reilly. JAMA 2021
183
25

ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas.
R C Bueno, R A Canevari, R A R Villacis, M A C Domingues, J R F Caldeira, R M Rocha, S A Drigo, S R Rogatto. Ann Oncol 2014
44
25

ATM Serine/Threonine Kinase and its Role in Pancreatic Risk.
Neha Nanda, Nicholas J Roberts. Genes (Basel) 2020
14
25

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. World J Gastroenterol 2018
703
25

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.
Giovanni Randon, Giovanni Fucà, Daniele Rossini, Alessandra Raimondi, Filippo Pagani, Federica Perrone, Elena Tamborini, Adele Busico, Giorgia Peverelli, Federica Morano,[...]. Sci Rep 2019
28
25

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
25


Tumour lineage shapes BRCA-mediated phenotypes.
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, Preethi Srinivasan, Shweta S Chavan, Noah D Friedman, Ezra Y Rosen, Allison L Richards, Nancy Bouvier, S Duygu Selcuklu,[...]. Nature 2019
200
25

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.
Kenneth L Pitter, Dana L Casey, Yue C Lu, Margaret Hannum, Zhigang Zhang, Xinmao Song, Isabella Pecorari, Biko McMillan, Jennifer Ma, Robert M Samstein,[...]. J Natl Cancer Inst 2021
20
25

Colloid carcinoma of the pancreas: review of selected pathological and clinical aspects.
Lukasz Liszka, Ewa Zielinska-Pajak, Jacek Pajak, Dariusz Gołka. Pathology 2008
23
25

Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations.
Zain Hannan, Shun Yu, Susan Domchek, Ronac Mamtani, Kim A Reiss. JNCI Cancer Spectr 2021
8
25

Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene.
Fang-Chi Hsu, Nicholas J Roberts, Erica Childs, Nancy Porter, Kari G Rabe, Ayelet Borgida, Chinedu Ukaegbu, Michael G Goggins, Ralph H Hruban, George Zogopoulos,[...]. JAMA Oncol 2021
15
25

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter, D Aderka, S Paluch-Shimon, B Kaufman, R Gershoni-Baruch,[...]. Br J Cancer 2014
263
25

Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
Daniel H Kwon, Jonathan Chou, Steven M Yip, Melissa A Reimers, Li Zhang, Francis Wright, Mallika S Dhawan, Hala T Borno, Arpita Desai, Rahul R Aggarwal,[...]. Cancer 2021
8
25

Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants.
Danielle Hutchings, Zhengdong Jiang, Michael Skaro, Matthew J Weiss, Christopher L Wolfgang, Martin A Makary, Jin He, John L Cameron, Lei Zheng, David S Klimstra,[...]. Mod Pathol 2019
10
25



ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
Andrea Mareckova, Jitka Malcikova, Nikola Tom, Karol Pal, Lenka Radova, David Salek, Andrea Janikova, Mojmir Moulis, Jana Smardova, Leos Kren,[...]. Leuk Lymphoma 2019
11
25

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.
Maeve A Lowery, Winston Wong, Emmet J Jordan, Jonathan W Lee, Yelena Kemel, Joseph Vijai, Diana Mandelker, Ahmet Zehir, Marinela Capanu, Erin Salo-Mullen,[...]. J Natl Cancer Inst 2018
129
25

Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings.
Ryota Sagami, Takao Sato, Kazuhiro Mizukami, Mitsuteru Motomura, Kazuhisa Okamoto, Satoshi Fukuchi, Yuichiro Otsuka, Takashi Abe, Hideki Ono, Kei Mori,[...]. Diagnostics (Basel) 2022
2
50

ATM mutations in patients with hereditary pancreatic cancer.
Nicholas J Roberts, Yuchen Jiao, Jun Yu, Levy Kopelovich, Gloria M Petersen, Melissa L Bondy, Steven Gallinger, Ann G Schwartz, Sapna Syngal, Michele L Cote,[...]. Cancer Discov 2012
325
25

Homologous repair deficiency score for identifying breast cancers with defective DNA damage response.
Ahrum Min, Kwangsoo Kim, Kyeonghun Jeong, Seongmin Choi, Seongyeong Kim, Koung Jin Suh, Kyung-Hun Lee, Sun Kim, Seock-Ah Im. Sci Rep 2020
16
25

Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
Yu Chen, Gang Chen, Jin Li, Ying-Ying Huang, Yi Li, Jing Lin, Li-Zhu Chen, Jian-Ping Lu, Yu-Qi Wang, Chang-Xi Wang,[...]. JAMA Netw Open 2019
30
25

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
25

Genomic analyses identify molecular subtypes of pancreatic cancer.
Peter Bailey, David K Chang, Katia Nones, Amber L Johns, Ann-Marie Patch, Marie-Claude Gingras, David K Miller, Angelika N Christ, Tim J C Bruxner, Michael C Quinn,[...]. Nature 2016
25

Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
Talia Golan, Maria Raitses-Gurevich, Robin K Kelley, Andrea G Bocobo, Ayelet Borgida, Rachna T Shroff, Spring Holter, Steven Gallinger, Daniel H Ahn, Dan Aderka,[...]. Oncologist 2017
61
25

FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study.
In Rae Cho, Huapyong Kang, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Chansik An, Mi-Suk Park,[...]. World J Gastrointest Oncol 2020
27
25

Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview.
Mateusz Kciuk, Beata Marciniak, Renata Kontek. Int J Mol Sci 2020
36
25

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Michael J Pishvaian, Edik M Blais, Jonathan R Brody, Emily Lyons, Patricia DeArbeloa, Andrew Hendifar, Sam Mikhail, Vincent Chung, Vaibhav Sahai, Davendra P S Sohal,[...]. Lancet Oncol 2020
206
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.